Cargando…
Expression of MTDH and IL-10 Is an Independent Predictor of Worse Prognosis in ER-Negative or PR-Negative Breast Cancer Patients
(1) Background: Tumor hypoxia leads to metastasis and certain immune responses, and interferes with normal biological functions. It also affects glucose intake, down-regulates oxidative phosphorylation, and inhibits fatty-acid desaturation regulated by hypoxia-inducible factor 1α (HIF-1α). Although...
Autores principales: | Chu, Pei-Yi, Wang, Shin-Mae, Chen, Po-Ming, Tang, Feng-Yao, Chiang, En-Pei Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601725/ https://www.ncbi.nlm.nih.gov/pubmed/33003428 http://dx.doi.org/10.3390/jcm9103153 |
Ejemplares similares
-
Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer
por: Alhammad, Rashed
Publicado: (2022) -
Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
por: Hu, Taobo, et al.
Publicado: (2021) -
MAT2A Localization and Its Independently Prognostic Relevance in Breast Cancer Patients
por: Chu, Pei-Yi, et al.
Publicado: (2021) -
Weight Loss Intervention in Survivors of ER/PR-negative Breast Cancer
por: Vitolins, Mara Z, et al.
Publicado: (2014) -
SU6668 suppresses proliferation of triple negative breast cancer cells through down-regulating MTDH expression
por: Wang, Lu, et al.
Publicado: (2013)